Notch Therapeutics
Laura Prochazka is a Senior Scientist in Cell Engineering at Notch Therapeutics, with prior experience as a Scientist II in Cell Engineering and Synthetic Biology at the same company. Between October 2016 and July 2021, Laura held a Postdoctoral Fellow position at the University of Toronto, focusing on gene circuit engineering and genome editing in human pluripotent stem cells, while also managing projects and supervising students. Laura's earlier experience includes a Postdoctoral Researcher role at ETH Zürich, where responsibilities included generating small RNA libraries and developing protocols for human induced pluripotent stem cells. Laura Prochazka earned a PhD in Mammalian Synthetic Biology from ETH Zürich, as well as a Master's and Bachelor's degree in Biochemistry from the University of Zurich.
This person is not in any offices
Notch Therapeutics
Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.